Skip to the page

Data / Federal rules / 2024-14706

Excise Tax on Designated Drugs; Procedural Requirements

The Internal Revenue Service published this final rule in the Federal Register on July 5, 2024. It took effect on August 5, 2024.

SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.

What the agency says

This document contains final regulations relating to the excise tax imposed on certain sales by manufacturers, producers, or importers of designated drugs. Specifically, the final regulations set forth procedural provisions relating to how taxpayers must report liability for such tax. The final regulations also except such tax from semimonthly deposit requirements. The final regulations affect manufacturers, producers, or importers of designated drugs dispensed, furnished, or administered to individuals under the terms of Medicare during certain statutory periods.

Key facts

Document number
2024-14706
Type
Final rule
Action
Final rule
Agency
Treasury Department; Internal Revenue Service
Published
July 5, 2024
Takes effect
August 5, 2024
Dates
Effective date: These regulations are effective on August 5, 2024.
Docket
TD 10003
Regulation ID (RIN)
1545-BQ93
Code of Federal Regulations
26 CFR 40; 26 CFR 47
Topics
Excise taxes; Reporting and recordkeeping requirements
Pages
5

The document on federalregister.gov PDF

Other documents from the Internal Revenue Service

Everything from the Internal Revenue Service · Rules on excise taxes · Rules on reporting and recordkeeping requirements · Published in July 2024

Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.